Vol. 40 | No. 2 | July-December 2012 Back

Open Access

Factors for Uncontrolled Hypertension among Hypertensive Patients Managed by Physicians Practicing in Metro Manila, Philippines

Noemi S. Pestaño, Eugenio B. Reyes, Ivan Noel G. Olegario
Dec 2012 DOI 10.69944/pjc.145fb914ba

Abstract

INTRODUCTION: The prevalence of hypertension has been rising in the Philippines, with the prevalence being highest in Metro Manila. Surveys showed that blood pressure was controlled in only 20% of hypertensive Filipino patients receiving treatment. 

OBJECTIVES: This study aims to determine factors associated with uncontrolled hypertension among hypertensive Filipinos being managed by physicians practicing in Metro Manila. 

METHODOLOGY: This is a cross-sectional study involving 1,000 hypertensive patients being treated by 100 physicians in Metro Manila. The patient’s medical records were reviewed, and patients were interviewed, to determine socio-demographics information and 13 patient- and physician-related factors. Based on the last recorded blood pressure, the patients were classified as either having controlled or uncontrolled hypertension. 

RESULTS: The prevalence of uncontrolled hypertension is 76%. Multivariate analysis showed that poor blood pressure control was associated with the presence of diabetes mellitus (OR 5.50, 95% CI 3.26-9.27); and current use of two or more drugs (OR 1.57, 95% CI 1.07-2.31). The use of angiotensin receptor blockers (OR 0.5680, 95% CI 0.40-0.79); the use of branded drugs (OR 0.69, 95% CI 0.49-0.98); and treatment supervision by an internist or cardiologist (OR 0.6965, 95% CI 0.4940-0.9818) were associated with good control.

References
  1. Sy RG, Dans AL, Punzalan FER, Amarillo ML, Velandia F for the FNRI-HDL Study Group. The prevalence of dyslipidemia, diabetes, hypertension, stroke and angina pectoris in the Philippines. Phil J Intern Med 2003;41:1-6. 
  2. The Seventh National Nutrition Survey. Taguig: Food and Nutrition Research Institute, 2008. 
  3. Yape IM, Tan M, Punzalan A, Neri R, Lapitan R, Chua Pp, Buan E, Bautista AJ Trinidad E, Arceo LP, Sison JA. Philippine Heart Association-Council on Hypertension Report on Survey of Hypertension and Target Organ Damage (PRESYON 2-TOD): A report on prevalence of hypertension, awareness, treatment profile and control rate. Phil J Cardiol 2007;35(1):1-9. 
  4. Sison JA, Bautista JA, Donato-Tan M, Buan ET, Cheng F, Deduyo RW, Lapitan RL, Nalundasan AM, Ong WT, Panlilio A, Pizarro MF, Uy NL. PHYTON 4: A nationwide survey on morbidity and mortality among hospitalized-based population in the Philippines: A report of the council on hypertension—Philippine Heat Association. Phil J Cardiol 2005;33:151-156. 
  5. Degli Esposti E, Di Martino M, Sturani A, Russo P, Dradi C, Falcinelli S, Buda S. Risk factors for uncontrolled hypertension in Italy. J Hum Hypertens 2004;18:207-213. 
  6. Rose AJ, Berlowitz DR, Orner MB, Kressin NR.Understanding uncontrolled hypertension: is it the patient or the provider? J Clin Hypertens (Greenwich) 2007;9:937-943. 
  7. Jafar TH, Jessani S, Jafary FH, Ishaq M, Orakzai R, Orakzai S, Levey AS, Chaturvedi N. General practitioners’ approach to hypertension in urban Pakistan: disturbing trends in practice. Circulation 2005;111:1278-1283. 
  8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-2572 .
License

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits use, share — copy and redistribute the material in any medium or format, adapt — remix, transform, and build upon the material, as long as you give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0/.